Insider trade

IBM (IBM)Director bought ~$101K

Michael Miebach, Director at IBM, bought ~$101K of IBM shares.

~$101K
Approx. value · 434 sh @ $233.33
434
Holds after · shares reported
Traded
Feb 25, 2026
Filed
Feb 26, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 22, 2025CongressDisclosed purchase of IBM — reported range $1,001 - $15,000
  2. Dec 12, 2025CongressDisclosed purchase of IBM — reported range $1,001 - $15,000
  3. Dec 18, 2025CongressDisclosed sale of IBM — reported range $1,001 - $15,000
  4. Dec 19, 2025CongressDisclosed purchase of IBM — reported range $1,001 - $15,000
  5. Jan 8, 2026Congress · 1 personMembers of Congress: 2 purchases
  6. Jan 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member
  7. Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
  8. Jan 30, 2026InsiderDirector purchased ~$304K of IBM shares in the open market
  9. Feb 2, 2026CongressDisclosed purchase of IBM — reported range $1,001 - $15,000
  10. Feb 10, 2026CongressDisclosed partial sale of IBM — reported range $1,001 - $15,000
  11. Feb 17, 2026Congress · 1 personMembers of Congress: 2 sales
  12. Feb 25, 2026 · this disclosureInsider · Their first buy on recordDirector purchased ~$101K of IBM shares in the open market

What came next

  1. Feb 25, 2026Insider · Their largest buy since 2021Director purchased ~$12K of IBM shares in the open market
  2. Feb 26, 2026Congress · 1 personMembers of Congress: 2 sales
  3. Mar 1, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
  4. Mar 10, 2026CongressDisclosed purchase of IBM — reported range $1,001 - $15,000
  5. Mar 13, 2026CongressDisclosed sale of IBM — reported range $15,001 - $50,000
  6. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  7. Apr 14, 2026CongressDisclosed purchase of IBM — reported range $15,001 - $50,000
  8. Apr 21, 2026Federal contract · $33.6M obligatedDepartment of Defense awarded IBM: $33.6M obligated to date
  9. Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
  10. Apr 24, 2026CongressDisclosed partial sale of IBM — reported range $1,001 - $15,000
  11. Apr 28, 2026Company filing · Form 8-K · Executive change, Bylaws or charterChanged a top executive or board member, and changed its bylaws, charter or fiscal year (and 1 more item)
  12. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  13. May 15, 2026CongressDisclosed sale of IBM — reported range $15,001 - $50,000
  14. May 21, 2026Congress · 1 personMembers of Congress: 2 purchases
  15. Jun 16, 2026CongressDisclosed sale of IBM — reported range $1,001 - $15,000
  16. Jun 22, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for IBM

For IBM, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 10 Congress trade reports, 74 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IBM page.

Other recent filings by Michael Miebach, Director

The full history of Michael Miebach, Director is on the profile page.

How this filing works

Other disclosures at IBM

Everything OQRO holds on this company is on its IBM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data